Tratamento farmacológico para endometriose

Camila Maria do Nascimento Santos, Luiz Eduardo Macedo Monte,José Chagas Pinheiro Neto,Higo José Neri da Silva,Antonia Filha Moreira de Melo,Sérgio Henrique Assunção Lacerda Borges,Alisson Camilo Martins Sousa, Juciara Carvalho de Oliveira, Fabiana de Souza Santana,Anna Letícia de Sousa Marinho, Márcia Araújo Gualberto,Ian Jhemes Oliveira Sousa,Rodrigo Lopes Gomes Gonçalves, Kelly Maria Rêgo da Silva,Iluska Martins Pinheiro

Research, Society and Development(2021)

引用 0|浏览4
暂无评分
摘要
Endometriosis is a gynecological disease characterized by the presence of endometrium as tissue-epithelium and stroma that develops outside the uterine cavity. It is a chronic, estrogen-dependent disease, is associated with pelvic pain, dysmenorrhea, dyspareunia and infertility. Given the great impact of this disease on the quality of life of women, there has been a growing interest in the discovery of new drugs that are more effective, tolerability and safety. For this, a literature review was carried out from articles published between 2008 and 2018 available regarding pharmacological treatments for endometriosis in the SCIENCE DIRECT and PUBMED databases. A total of 223 articles published in the last 10 years were found in Portuguese and English. After evaluating the articles, 15 articles were selected for the present study, which complied with all the eligibility criteria proposed in the methodology. It was concluded that we can count on several types of treatments for endometriosis, but most have the objective of treating the symptoms associated with endometriosis. Currently, the specific treatment we can count on is dienogeste. In addition, there are many studies in search of new drugs and promising treatments for this pathology. Thus, more research is needed regarding the theme and that the pharmacist plays a fundamental role in the adherence to the patient's treatment.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要